Acute thrombosis in an aortic prosthesis: All mechanical valves are not the same

Hospital Medicine

Volumn 62, Issue 12, 2001, Pages 788-789

  Burgess, Malcolm ^a,b,c   Millane, Teri ^a   Deiraniya, Abdul ^a  

^a Countess of Chester Hospital ^*  (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AGED; AORTA VALVE; ARTICLE; CASE REPORT; DECISION MAKING; HEART VALVE PROSTHESIS; HUMAN; MALE; PROSTHESIS FAILURE; THROMBOSIS;

AGED; ANTICOAGULANTS; AORTIC VALVE; DECISION MAKING; HEART VALVE PROSTHESIS; HUMANS; MALE; PROSTHESIS FAILURE; THROMBOSIS;

EID: 0035747603     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2001.62.12.1712     Document Type: Article

References (17)

1. Acar J, lung B. Boisscl JP et al (1996) AREVA: multiccntrc randomized comparison of lowdose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 94(9): 2107-12
2. Aroin KV Nicoloff DM. Kersten TE, Northrup WE Lindsay WG. Emery RW (1989) Ten years' experience with the St. Jude Medical Valve prosthesis. Ann Tlitmtc Sura 47(6): 831 -1
3. Barnhorst DA. Oxman HA, Connolly DC (1976) Isolated replacement of the mitral valve with the Starr-Edwards prosthesis. J. Thorac Cardiovasc Surg 71(2): 230 7
4. Butchart E(i, Lewis PA, Kulatilakc EN. Breckenridge IM (1988) Anticoagulation variability between centres: implications for comparative prosthetic valve assessment. Eur J Canliothoiw Surg 2(2): 72-81
5. Butchart EG. Lewis PA. Bethel JA. Breckenridge IM (1991) Adjusting anticoagulation to prosthesis thrombogenicity and patient risk lactors. Recommendations for the Medtronic Hall valve. Circulation 84(5 Suppl): III 61 9
6. Gagnon RM. Beaudet R. Leinire J. Carignan L. Guimond C, Cousincau G (19K4) Strcptokinase thrombolysis of a chronically throinbosed mitral prosthetic valve. Cathet Cimliimisc Diagn lu(1): 5-10
7. Horstkotte D, Burckhardt D (1995) Prosthetic valve thrombosis. J Heart Valve Dis 4(2): 141-53
8. Horstkotte D. Schulte H, Bircks W. Strauer B (1993a) Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prosthesis. J. Heart l'aire Dis 2(3): 291-301
9. Horstkotte D, Bergemann R. Allhaus U et al (I993b) (ierman experience with low-intensity anticoagulation (GEIJA): protocol of a multi-center randomized, prospective study with the St. Jude Medical Valve. J Heart Valve Dis 2(4): 411 9
10. Horstkotte D. Schulte HD. Bircks W, Strauer BE (1994) Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical Prosthesis. J. Thuruc Canliovasc Surg 107(4): 1 136-45
11. Husebye D. Pluth J. Piehler J el al (1983) Kooperation on prosthetic heart valves. An analysis of risk factors in 552 patients. J Thorac Cardiovasc Surg 86(4): 543-52
12. Kvidal P. Bergstrom R. Malm T. Stahle E (2000) Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart .121(13): 1099-111
13. Malergue C. Maribas P, Vignon P. Temkine J. Bical (X Gueret P (1992) High incidence of asymptomatic thrombosis of mechanical prostheses in the early post-operative period: demonstration by systematic transoesophagcal echocardiography [Abstract]. F.ur Heart J 13(AbstrSuppl): 237
14. Mitchell RS, Miller DC, Stinson EB (19X6) Significant patient-related determinants of prosthetic valve performance. J Thorac Cardiovasc Surg 91(6): 807-17
15. Piper C, Schulte HD. Horstkolle D (1995) Optimization of oral anticoagulation for patients with mechanical heart valve prosthcses. J Heart Valve Dis 4(2): 127-37
16. Starek P. Beaudet R. Hall K (19X7) The Medtronic-llall valve: development and clinical experience. Cardiac Surgery 1(2): 223 36
17. Zeien LB. Matt EC (1990) Cardiac valve prostheses at autopsy. Arch Palhol iah Meil 114(9): 933-7